The company established to commercialise a number of tissue engineered products for the treatment of skin defects using autologous cell replacement.
The tissue engineering processes to grow skin cells from a small sample of the patient’s own skin. The skin is then applied to the wound to ensure increased healing rates with minimal scarring.
Our proprietary skin replacement products, including CellSpray and ReCell offer clinicians a range of options for the treatment of burns, scars, chronic wounds, cosmetic surgery procedures and other types of epidermal trauma.
